{"AllianceGenome": "12000", "HGNC": "12000", "MIM": "602143", "_id": "7159", "_version": 1, "accession": {"genomic": ["AC096542.2", "CH471100.2", "CP068277.2", "KT584027.1", "NC_000001.11", "NC_060925.1", "NG_029950.1"], "protein": ["AAA21597.1", "AAC50557.1", "AAH40247.1", "AAH46150.2", "AAH58918.2", "BAG57677.1", "BAG58037.1", "BAG58337.1", "BAH11835.1", "BAH14387.1", "BAH14474.1", "CAC83012.1", "EAW93247.1", "EAW93248.1", "NP_001026855.2", "NP_005417.1", "Q13625.2", "XP_011542570.1", "XP_011542571.1", "XP_047285454.1", "XP_054194551.1", "XP_054194552.1", "XP_054194553.1"], "rna": ["AA961496.1", "AI042183.1", "AJ318888.2", "AK294432.1", "AK294654.1", "AK294964.1", "AK295378.1", "AK316016.1", "AK316103.1", "AL357233.1", "BC040247.1", "BC046150.1", "BC058918.1", "BX425756.2", "NM_001031685.3", "NM_005426.3", "U09582.1", "U58334.1", "XM_011544268.3", "XM_011544269.3", "XM_047429498.1", "XM_054338576.1", "XM_054338577.1", "XM_054338578.1"], "translation": [{"protein": "AAH58918.2", "rna": "BC058918.1"}, {"protein": "AAH40247.1", "rna": "BC040247.1"}, {"protein": "AAH46150.2", "rna": "BC046150.1"}, {"protein": "XP_011542570.1", "rna": "XM_011544268.3"}, {"protein": "XP_054194551.1", "rna": "XM_054338576.1"}, {"protein": "BAH11835.1", "rna": "AK294654.1"}, {"protein": "XP_047285454.1", "rna": "XM_047429498.1"}, {"protein": "BAG58337.1", "rna": "AK295378.1"}, {"protein": "NP_001026855.2", "rna": "NM_001031685.3"}, {"protein": "BAH14387.1", "rna": "AK316016.1"}, {"protein": "XP_054194552.1", "rna": "XM_054338577.1"}, {"protein": "AAC50557.1", "rna": "U58334.1"}, {"protein": "XP_011542571.1", "rna": "XM_011544269.3"}, {"protein": "CAC83012.1", "rna": "AJ318888.2"}, {"protein": "NP_005417.1", "rna": "NM_005426.3"}, {"protein": "XP_054194553.1", "rna": "XM_054338578.1"}, {"protein": "AAA21597.1", "rna": "U09582.1"}, {"protein": "BAG58037.1", "rna": "AK294964.1"}, {"protein": "BAH14474.1", "rna": "AK316103.1"}, {"protein": "BAG57677.1", "rna": "AK294432.1"}]}, "alias": ["53BP2", "ASPP2", "BBP", "P53BP2", "PPP1R13A"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "disputed", "classification_date": "2023-05-18T16:00:00.000Z", "disease_label": "open-angle glaucoma", "gcep": "Glaucoma and Neuro-Ophthalmology Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005338", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_05ac2b0b-5f6d-4227-ad08-0bb6c852583f-2023-05-18T160000.000Z", "sop": "SOP10"}}, "ensembl": {"gene": "ENSG00000143514", "protein": ["ENSP00000341957", "ENSP00000375750", "ENSP00000417174", "ENSP00000420225"], "transcript": ["ENST00000343537", "ENST00000391878", "ENST00000464172", "ENST00000465119", "ENST00000472180", "ENST00000473135", "ENST00000481128", "ENST00000483398", "ENST00000489310", "ENST00000490896", "ENST00000494100", "ENST00000496282", "ENST00000498843"], "translation": [{"protein": "ENSP00000341957", "rna": "ENST00000343537"}, {"protein": "ENSP00000375750", "rna": "ENST00000391878"}, {"protein": "ENSP00000417174", "rna": "ENST00000483398"}, {"protein": "ENSP00000420225", "rna": "ENST00000494100"}], "type_of_gene": "protein_coding"}, "entrezgene": "7159", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 37.597701242, "exp_mis": 379.597307737, "exp_syn": 164.998578353, "lof_z": 4.13532816923688, "mis_z": 1.09449678846507, "mu_lof": 2.73912001801e-06, "mu_mis": 3.34308034084e-05, "mu_syn": 1.41666674945e-05, "n_lof": 12.0, "n_mis": 336.0, "n_syn": 163.0, "p_li": 0.00201851813532473, "p_null": 7.44509508241614e-06, "p_rec": 0.997974036769593, "syn_z": 0.096457320996121}, "bp": 3405, "cds_end": 224033382, "cds_start": 223968554, "n_exons": 18, "nonpsych": {"exp_lof": 33.67293269, "exp_mis": 343.215588575, "exp_syn": 148.98301969, "lof_z": 4.00648575528262, "mis_z": 1.28547515730423, "mu_lof": 2.73912001801e-06, "mu_mis": 3.34308034084e-05, "mu_syn": 1.41666674945e-05, "n_lof": 10.0, "n_mis": 296.0, "n_syn": 147.0, "p_li": 0.0142398504074318, "p_null": 1.30184701004864e-05, "p_rec": 0.985747131122468, "syn_z": 0.102286385188749}, "nontcga": {"exp_lof": 34.555125965, "exp_mis": 349.194787848, "exp_syn": 151.763937365, "lof_z": 3.78503814816509, "mis_z": 1.23159781413901, "mu_lof": 2.73912001801e-06, "mu_mis": 3.34308034084e-05, "mu_syn": 1.41666674945e-05, "n_lof": 12.0, "n_mis": 303.0, "n_syn": 154.0, "p_li": 0.000674701050712241, "p_null": 3.59528380737516e-05, "p_rec": 0.999289346111214, "syn_z": -0.114928916861171}, "transcript": "ENST00000343537.7"}, "exons": [{"cdsend": 223845680, "cdsstart": 223780852, "chr": "1", "position": [[223779892, 223780894], [223784114, 223784314], [223789007, 223789174], [223792388, 223792522], [223793302, 223793440], [223795814, 223796590], [223798214, 223798677], [223799898, 223800047], [223800699, 223800810], [223802115, 223802344], [223802730, 223802895], [223803270, 223803452], [223804173, 223804348], [223806845, 223806947], [223810430, 223810513], [223814239, 223814353], [223821219, 223821367], [223845653, 223845947]], "strand": -1, "transcript": "NM_001031685", "txend": 223845947, "txstart": 223779892}, {"cdsend": 223806932, "cdsstart": 223780852, "chr": "1", "position": [[223779892, 223780894], [223784114, 223784314], [223789007, 223789174], [223792388, 223792522], [223793302, 223793440], [223795814, 223796590], [223798214, 223798677], [223799898, 223800047], [223800699, 223800810], [223802115, 223802344], [223802730, 223802895], [223803270, 223803452], [223804173, 223804348], [223806845, 223806947], [223810430, 223810513], [223814239, 223814353], [223818205, 223818337], [223821219, 223821367], [223845653, 223845972]], "strand": -1, "transcript": "NM_005426", "txend": 223845972, "txstart": 223779892}], "exons_hg19": [{"cdsend": 224033382, "cdsstart": 223968554, "chr": "1", "position": [[223967594, 223968596], [223971816, 223972016], [223976709, 223976876], [223980090, 223980224], [223981004, 223981142], [223983516, 223984292], [223985916, 223986379], [223987600, 223987749], [223988401, 223988512], [223989817, 223990046], [223990432, 223990597], [223990972, 223991154], [223991875, 223992050], [223994547, 223994649], [223998132, 223998215], [224001941, 224002055], [224008921, 224009069], [224033355, 224033649]], "strand": -1, "transcript": "NM_001031685", "txend": 224033649, "txstart": 223967594}, {"cdsend": 223994634, "cdsstart": 223968554, "chr": "1", "position": [[223967594, 223968596], [223971816, 223972016], [223976709, 223976876], [223980090, 223980224], [223981004, 223981142], [223983516, 223984292], [223985916, 223986379], [223987600, 223987749], [223988401, 223988512], [223989817, 223990046], [223990432, 223990597], [223990972, 223991154], [223991875, 223992050], [223994547, 223994649], [223998132, 223998215], [224001941, 224002055], [224005907, 224006039], [224008921, 224009069], [224033355, 224033674]], "strand": -1, "transcript": "NM_005426", "txend": 224033674, "txstart": 223967594}], "generif": [{"pubmed": 12694406, "text": "ASPP2 is a negative regulator of the neddylation pathway through specific interaction with APP-BP1 and suggest that dysfunction of the APP-BP1 interaction with APP may be one cause of Alzheimer's disease"}, {"pubmed": 14766226, "text": "TP53BP2 encodes two mRNA species, either with (53BP2) or without exon 3 (ASPP2), by alternative splicing in various cell lines and tissues"}, {"pubmed": 15592436, "text": "downstream of E2F, suggesting that it functions as a common link between the p53/p73 and Rb/E2F apoptotic pathways"}, {"pubmed": 15731768, "text": "target of E2F transcription factor"}, {"pubmed": 15757645, "text": "ASPP2 CpG island aberrant methylation could be one molecular and genetic alteration in wild-type p53 tumours."}, {"pubmed": 15782125, "text": "Mdm2 and mdmx prevent ASPP1 and ASPP2 from stimulating the apoptotic function of p53 by binding and inhibiting the transcriptional activity of p53."}, {"pubmed": 15986435, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15986435, "text": "results suggest that the tumor protein p53 binding protein(TP53BP2) locus is associated with susceptibility to gastric cancer in the Korean population"}, {"pubmed": 16091363, "text": "ASPP2/(53BP2L) expression regulation by proteasomal degradation modulates p53 apoptotic function"}, {"pubmed": 16098144, "text": "In this study we explored the effect of NF-kappaB activation elicited by a physiological NF-kappaB inducer, interleukin-1beta (IL-1beta), and anti-apoptotic Bcl-2 family proteins on the 53BP2S-mediated apoptosis"}, {"pubmed": 16139958, "text": "role of ASPP1, ASPP2, and iASPP as apoptotic specific regulators of p53 [review]"}, {"pubmed": 17594908, "text": "suggest a possible role for the N-termini of ASPP proteins in binding to other proteins in the apoptotic response network"}, {"pubmed": 17965023, "text": "53BP2S interacts and modulates the insulin signals mediated by insulin receptor substrates."}, {"pubmed": 18719108, "text": "identifies the interaction sites of Bcl-2 and its homologues with ASPP2"}, {"pubmed": 18793611, "text": "Together these results identify ASPP2 as a bona fide DDA3 interacting protein, and suggest that the ASPP2/DDA3 interaction may inhibit ASPP2 in stimulating the apoptotic signaling of p53."}, {"pubmed": 19246451, "text": "ASPP2 primarily binds to the core domain of p53, whereas iASPP predominantly interacts with a linker region adjacent to the core domain."}, {"pubmed": 19507243, "text": "ASPP2(ANK-SH3) binds NFkappaB(p65) in a similar manner to its natural inhibitor IkappaB, suggesting a possible novel role for ASPP2 as an NFkappaB inhibitor"}, {"pubmed": 19536092, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19539330, "text": "bcl2 -938C/C genotype has worse prognosis and lower survival in patients with renal cell carcinoma. In addition, the bcl2 -938C/A single nucleotide polymorphism was shown to be an independent adverse prognostic factor for renal cell carcinoma"}, {"pubmed": 20034025, "text": "ASPP1 and ASPP2 genes are frequently down-regulated by DNA methylation in HBV-positive hepatocellular carcinoma, which may play important roles in the development of HCC"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20800603, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21183427, "text": "study was to determine localization pattern of ASPP-2 in a variety of normal and malignant human tissues; study indicates that ASPP-2 has a specific distribution pattern within tissues and cells in a way that appears to be related to differentiation"}, {"pubmed": 21189257, "text": "PP1A and ASPP2 play a critical role in promoting TAZ function by antagonizing the LATS kinase through TAZ dephosphorylation."}, {"pubmed": 21562218, "text": "Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host"}, {"pubmed": 22169642, "text": "Methylation in the promoter region of ASPP2 gene was not detected in lung cancer or adjacent non-neoplastic lung tissue."}, {"pubmed": 22552744, "text": "the mRNA expression of ASPP1 and ASPP2 was frequently dowregulated in tumor tissues, and this decreased significantly in samples expressing wild-type p53"}, {"pubmed": 23088536, "text": "When the Px(T)PxR motif is deleted or mutated via insertion of a phosphorylation site mimic (T311D), PP-1c fails to bind to all three ASPP proteins, ASPP1, ASPP2 and iASPP."}, {"pubmed": 23248303, "text": "ASPP2 binds to Ras-GTP at the plasma membrane and stimulates Ras-induced signaling and pERK1/2 levels via promoting Ras-GTP loading, B-Raf/C-Raf dimerization, and C-Raf phosphorylation."}, {"pubmed": 23392125, "text": "ASPP1 and ASPP2 cooperate with RAS to enhance p53-induced apoptosis suggests that loss of ASPP1 or ASPP2 expression may be a frequent event in human cancers with mutant RAS."}, {"pubmed": 23472201, "text": "the intramolecular interaction in ASPP2 regulates its binding to p53CD and ASPP2 Ank-SH3 binds Bcl-2 and NFkappaB via distinct sites"}, {"pubmed": 23528480, "text": "higher rate Helicobacter pylori infection, an increased expression of inhibitor of apoptosis stimulating protein of p53 (iASPP), and decreased expression of apoptosis-stimulating of p53 protein 2(ASPP2) was present in gastric cancer"}, {"pubmed": 23606740, "text": "FIH-1 depletion did lead to impaired binding of Par-3 to ASPP2."}, {"pubmed": 23644657, "text": "our studies demonstrate the role of Siah2 in regulation of tight junction integrity and cell polarity under hypoxia, through its regulation of ASPP2 stability."}, {"pubmed": 23671128, "text": "We also unveiled a possible mechanistic link between ASPP2 and Csk/Src signaling pathway, implicating the multiple cellular functions of ASPP2."}, {"pubmed": 24312201, "text": "Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure."}, {"pubmed": 24312625, "text": "phosphorylation of ASPP2 by RAS/MAPK pathway provides a novel link between RAS and p53 in regulating apoptosis"}, {"pubmed": 24474782, "text": "Disruption of CagA and ASPP2 binding alters the function of ASPP2 and leads to the decreased survival of H. pylori-infected cells"}, {"pubmed": 25032846, "text": "CHOP is critical for mediating ASPP2-induced autophagic apoptosis by decreasing Bcl-2 expression and maintaining nuclear ASPP2-Bcl-2 complexes."}, {"pubmed": 25256142, "text": "ASPP2 may participate in the lipid metabolism of non-alcoholic steatohepatitis and attenuate liver failure."}, {"pubmed": 25344754, "text": "ASPP2 prevents beta-catenin from transactivating ZEB1 directly by forming an ASPP2-beta-catenin-E-cadherin ternary complex"}, {"pubmed": 25360797, "text": "ASPP2 directly induces the dephosphorylation and activation of junctional YAP"}, {"pubmed": 25436413, "text": "these observations reveal that Itch and Yap1 have antagonistic roles in the regulation of ASPP2 protein stability through competing post-translational regulatory mechanism of ASPP2."}, {"pubmed": 25534115, "text": "this study revealed a novel function of ASPP2 in modulating autophagy and apoptosis."}, {"pubmed": 25660448, "text": "ASPP1/2 interacted with centrosome linker protein C-Nap1. Co-depletion of ASPP1 and ASPP2 inhibited re-association of C-Nap1 with centrosome at the end of mitosis."}, {"pubmed": 25963096, "text": "These results identify previously uncharacterized regions distributed throughout the protein sequence of ASPP2 as determinants of CagA binding, providing mechanistic insight into apoptosis reprogramming by CagA."}, {"pubmed": 26438046, "text": "ASSP2 expression is lower in cancerous tissues and decreased ASPP2 lead to higher cancer cells proliferation and autophagic flux, which contribute to the gemcitabine resistance."}, {"pubmed": 26595804, "text": "ASPP1/2-PP1 complexes are required for chromosome segregation and kinetochore-microtubule attachments."}, {"pubmed": 26663100, "text": "miR-548d-3p/TP53BP2 pathway is critically involved in the proliferation and apoptosis of breast cancer cells and may be new therapeutic target of breast cancer cells."}, {"pubmed": 27437940, "text": "Our results suggest that Gal-1 and ASPP2 functionally compete in nanocluster for active Ras on the plasma membrane. ASPP2 dominates the biological outcome, thus switching from a Gal-1 supported growth-promoting setting to a senescence inducing and stemness suppressive program in cancer cells. Our results support Ras nanocluster as major integrators of tumour fate decision events."}, {"pubmed": 27447114, "text": "These findings identify TP53BP2 as a strong candidate causative gene for central nervous system (CNS) defects in 1q41q42 microdeletion syndrome."}, {"pubmed": 27473084, "text": "Downregulated expression of ASPP2 is associated with hepatocellular carcinoma."}, {"pubmed": 27929537, "text": "These data together implicated a critical impact of MiR-205/ASPP2 on promoting epithelial-mesenchymal transition."}, {"pubmed": 27929538, "text": "ASPP2 is a key regulator of BECN1-dependent autophagy."}, {"pubmed": 27939881, "text": "ASPP2 suppresses p53 target gene transactivation, promoter occupancy, and endogenous p53 target gene expression in response to DNA damage"}, {"pubmed": 28103919, "text": "Results showed that protein expression levels of ASPP2 and P53 were significantly higher in esophageal squamous cell carcinoma tissues than in paired noncancerous tissues."}, {"pubmed": 28179588, "text": "Expression levels of TP53BP2, FBXO28, and FAM53A genes were associated with patient survival specifically in ER-positive, TP53-mutated tumors."}, {"pubmed": 28351301, "text": "In this study, in recombinant adenovirus-ASPP2-infected HepG2 cells, ASPP2 overexpression induces amphiregulin expression in a p53-dependent manner"}, {"pubmed": 28400336, "text": "ASPP2 suppresses invasion, peritoneal dissemination and TGF-beta1-induced EMT by inhibiting Smad7 degradation mediated by ITCH in gastric cancer cells."}, {"pubmed": 29568874, "text": "Study have provided evidence that ASPP2 has an inhibitory influence on triplenegative breast cancer (TNBC) growth and metastasis, and that this may rely on using the PI3K/AKT pathway in a p53independent manner."}, {"pubmed": 29747775, "text": "the abnormal expression of ASPP2 may play an important role for development and metastasis in esophageal squamous cell carcinoma."}, {"pubmed": 30389910, "text": "Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC/GLI1 pathway."}, {"pubmed": 30528232, "text": "p53 activation and XIAP suppression were two independent ways that ASPP2 enhance the sensitivity of chemotherapy."}, {"pubmed": 30796685, "text": "Age-related miR-219a-5p can attenuate hepatic ischemia/reperfusion injury through inhibiting TP53BP2 and downstream TP53-dependent apoptosis of hepatic cells in mice."}, {"pubmed": 30952616, "text": "Our data demonstrates that ASPP2kappa plays a distinctive role as an antiapoptotic regulator of the TP53 checkpoint, rendering cells to a more aggressive phenotype as evidenced by proliferation and apoptosis rates - and ASPP2kappa expression results in acquisition of genomic mutations, a first initiating step in leukemogenesis."}, {"pubmed": 31015291, "text": "identified a previously unreported Merlin-binding protein, apoptosis-stimulated p53 protein 2 (ASPP2, also called Tp53bp2), that bound to closed-conformation Merlin predominately through the FERM domain."}, {"pubmed": 31685796, "text": "ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma."}, {"pubmed": 31878994, "text": "ASPP2 inhibits the autophagy of HepG2 cells by activating mTOR pathway in a p53-independent manner."}, {"pubmed": 31964836, "text": "CagA-ASPP2 interaction is a key event that promotes remodeling of the partitioning-defective (PAR) polarity complex and leads to loss of cell polarity of infected cells."}, {"pubmed": 32266459, "text": "ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer."}, {"pubmed": 32420372, "text": "Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2."}, {"pubmed": 32987288, "text": "Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer."}, {"pubmed": 34085409, "text": "ASPP2 inhibits hepatitis B virus replication by preventing nucleus translocation of HSF1 and attenuating the transactivation of ATG7."}, {"pubmed": 35177595, "text": "ASPP2 maintains the integrity of mechanically stressed pseudostratified epithelia during morphogenesis."}, {"pubmed": 35780096, "text": "Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)."}, {"pubmed": 36877271, "text": "mRNA sequencing and CyTOF analysis revealed ASPP2 altered the response patterns of hepatocellular carcinoma HepG2 cells to usnic acid."}, {"pubmed": 37750869, "text": "ASPP2 binds to hepatitis C virus NS5A protein via an SH3 domain/PxxP motif-mediated interaction and potentiates infection."}, {"pubmed": 37858684, "text": "Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-alpha-treated patients with chronic hepatitis B."}], "genomic_pos": {"chr": "1", "end": 223845954, "ensemblgene": "ENSG00000143514", "start": 223779893, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 224033674, "start": 223967601, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 9748285, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0045786", "pubmed": 14729977, "qualifier": "involved_in", "term": "negative regulation of cell cycle"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0072332", "pubmed": 11684014, "qualifier": "involved_in", "term": "intrinsic apoptotic signaling pathway by p53 class mediator"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1900119", "pubmed": 14985081, "qualifier": "involved_in", "term": "positive regulation of execution phase of apoptosis"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 19377511, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": [10646860, 14985081, 19377511], "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005737", "pubmed": 15782125, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030054", "qualifier": "located_in", "term": "cell junction"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0048471", "pubmed": 10646860, "qualifier": "colocalizes_with", "term": "perinuclear region of cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0048471", "pubmed": 14985081, "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0002039", "qualifier": "enables", "term": "p53 binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0002039", "pubmed": 14985081, "qualifier": "enables", "term": "p53 binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [8875926, 10646860, 11684014, 12694406, 14729977, 14985081, 15161933, 15231748, 18275817, 18448430, 18719108, 19377511, 21513714, 21988832, 21998301, 22321011, 24366813, 24855949, 25344754, 25436413, 25502805, 25963096, 26496610, 28330616, 28514442, 31515488, 36931259], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0017124", "qualifier": "enables", "term": "SH3 domain binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 18448430, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042803", "pubmed": 25963096, "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0051059", "pubmed": 10498867, "qualifier": "enables", "term": "NF-kappaB binding"}]}, "homologene": {"genes": [[7955, 407983], [8364, 548790], [9031, 421329], [9544, 705383], [9598, 457766], [9606, 7159], [9615, 490397], [9913, 514474], [10090, 209456], [10116, 305025]], "id": 3959}, "interpro": [{"desc": "SH3 domain", "id": "IPR001452", "short_desc": "SH3_domain"}, {"desc": "Ankyrin repeat", "id": "IPR002110", "short_desc": "Ankyrin_rpt"}, {"desc": "Ubiquitin-like domain superfamily", "id": "IPR029071", "short_desc": "Ubiquitin-like_domsf"}, {"desc": "SH3-like domain superfamily", "id": "IPR036028", "short_desc": "SH3-like_dom_sf"}, {"desc": "Ankyrin repeat-containing domain superfamily", "id": "IPR036770", "short_desc": "Ankyrin_rpt-contain_sf"}, {"desc": "Apoptosis-stimulating of p53 protein 1/2", "id": "IPR047163", "short_desc": "ASPP1/2"}, {"desc": "Apoptosis-stimulating protein of p53 protein 2, RA domain", "id": "IPR047166", "short_desc": "ASPP2_RA"}, {"desc": "Apoptosis-stimulating of p53 protein 2-like, RA domain", "id": "IPR048942", "short_desc": "ASPP2-like_RA"}], "ipi": ["IPI00337588", "IPI00873482", "IPI00939154", "IPI00945278"], "map_location": "1q41", "name": "tumor protein p53 binding protein 2", "other_names": ["BCL2-binding protein", "apoptosis-stimulating of p53 protein 2", "apoptosis-stimulating protein of p53, 2", "renal carcinoma antigen NY-REN-51", "tumor suppressor p53-binding protein 2"], "pantherdb": {"HGNC": "12000", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2138319", "ortholog_type": "LDO", "panther_family": "PTHR24131", "taxid": 10090, "uniprot_kb": "Q8CG79"}, {"RGD": "1305461", "ortholog_type": "LDO", "panther_family": "PTHR24131", "taxid": 10116, "uniprot_kb": "F1M5H6"}, {"Ensembl": "ENSGALG00000042816", "ortholog_type": "LDO", "panther_family": "PTHR24131", "taxid": 9031, "uniprot_kb": "A0A1D5NY23"}, {"ZFIN": "ZDB-GENE-050208-453", "ortholog_type": "O", "panther_family": "PTHR24131", "taxid": 7955, "uniprot_kb": "F1QWN1"}, {"ZFIN": "ZDB-GENE-040516-8", "ortholog_type": "LDO", "panther_family": "PTHR24131", "taxid": 7955, "uniprot_kb": "F1R419"}, {"WormBase": "WBGene00000146", "ortholog_type": "O", "panther_family": "PTHR24131", "taxid": 6239, "uniprot_kb": "Q9XVN3"}, {"FlyBase": "FBgn0034606", "ortholog_type": "O", "panther_family": "PTHR24131", "taxid": 7227, "uniprot_kb": "Q86BG1"}], "uniprot_kb": "Q13625"}, "pathway": {"kegg": {"id": "hsa04390", "name": "Hippo signaling pathway - Homo sapiens (human)"}, "pid": {"id": "p53downstreampathway", "name": "Direct p53 effectors"}, "reactome": [{"id": "R-HSA-109581", "name": "Apoptosis"}, {"id": "R-HSA-109606", "name": "Intrinsic Pathway for Apoptosis"}, {"id": "R-HSA-114452", "name": "Activation of BH3-only proteins"}, {"id": "R-HSA-139915", "name": "Activation of PUMA and translocation to mitochondria"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-3700989", "name": "Transcriptional Regulation by TP53"}, {"id": "R-HSA-5357801", "name": "Programmed Cell Death"}, {"id": "R-HSA-5633007", "name": "Regulation of TP53 Activity"}, {"id": "R-HSA-5633008", "name": "TP53 Regulates Transcription of Cell Death Genes"}, {"id": "R-HSA-6803204", "name": "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release"}, {"id": "R-HSA-6803205", "name": "TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain"}, {"id": "R-HSA-6803211", "name": "TP53 Regulates Transcription of Death Receptors and Ligands"}, {"id": "R-HSA-6804759", "name": "Regulation of TP53 Activity through Association with Co-factors"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}]}, "pdb": ["1YCS", "2UWQ", "4A63", "4IRV", "6GHM", "6HKP"], "pfam": ["PF00018", "PF12796", "PF21801"], "pharmgkb": "PA36681", "pharos": {"target_id": 1094, "tdl": "Tbio"}, "pir": "I38607", "prosite": ["PS50002", "PS50088", "PS50297"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF257479", "relationship": "is"}, {"id": "GNF257480", "relationship": "is"}, {"id": "GNF257481", "relationship": "is"}, {"id": "GNF257482", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF049073", "relationship": "is"}, {"id": "GNF049099", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF014817", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF233504", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF099066", "relationship": "is"}, {"id": "GNF138721", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_029950.1"], "protein": ["NP_001026855.2", "NP_005417.1", "XP_011542570.1", "XP_011542571.1", "XP_047285454.1", "XP_054194551.1", "XP_054194552.1", "XP_054194553.1"], "rna": ["NM_001031685.3", "NM_005426.3", "XM_011544268.3", "XM_011544269.3", "XM_047429498.1", "XM_054338576.1", "XM_054338577.1", "XM_054338578.1"], "translation": [{"protein": "XP_047285454.1", "rna": "XM_047429498.1"}, {"protein": "NP_001026855.2", "rna": "NM_001031685.3"}, {"protein": "NP_005417.1", "rna": "NM_005426.3"}, {"protein": "XP_054194553.1", "rna": "XM_054338578.1"}, {"protein": "XP_054194552.1", "rna": "XM_054338577.1"}, {"protein": "XP_011542570.1", "rna": "XM_011544268.3"}, {"protein": "XP_054194551.1", "rna": "XM_054338576.1"}, {"protein": "XP_011542571.1", "rna": "XM_011544269.3"}]}, "reporter": {"HG-U133_Plus_2": "203120_at", "HG-U95Av2": ["1860_at", "34822_at"], "HTA-2_0": "TC01003874.hg.1", "HuEx-1_0": "2457842", "HuGene-1_1": "7924526", "HuGene-2_1": "16699706"}, "summary": "This gene encodes a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 interacting proteins. The protein contains four ankyrin repeats and an SH3 domain involved in protein-protein interactions. It is localized to the perinuclear region of the cytoplasm, and regulates apoptosis and cell growth through interactions with other regulatory molecules including members of the p53 family. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].", "symbol": "TP53BP2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C0812245"}, "unigene": "Hs.523968", "uniprot": {"Swiss-Prot": "Q13625", "TrEMBL": ["H0Y847", "H7C5L8"]}, "wikipedia": {"url_stub": "TP53BP2"}}